Charles River Laboratories CRL Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $4.03B+0.1% | $4.02B-0.9% | $4.02B-0.9% | $4.03B-1.2% | $4.02B-2.2% | ||
| $724.7M-2.4% | $743.07M-1.1% | $742.65M-1.3% | $764.27M+4.8% | $742.51M-2.2% | ||
| —— | —— | —— | —— | —— | ||
| $105.89M-11.1% | $107.03M-15.3% | $111.49M-15.3% | $116.37M-13.8% | $119.17M-13.2% | ||
| —— | —— | -$57.38M-150% | -$32.17M-131% | -$34.56M-133% | ||
| —— | —— | $60.47M-33.3% | $49.77M-47.3% | $56.44M-42.6% | ||
| -$184.65M— | -$144.34M— | —— | —— | —— | ||
| -4.6%— | -3.6%— | —— | —— | —— | ||
| -$3.70— | -$2.90— | —— | —— | —— | ||
| $702.83M-11.3% | $710.81M-12.1% | $787.25M-9.3% | $773.89M-13.3% | $791.99M-11.8% | ||
| 17.5%-2.2pp | 17.7%-2.3pp | 19.6%-1.8pp | 19.2%-2.7pp | 19.7%-2.1pp | ||
| $352.73M-10.8% | $307.5M-31.1% | $360.11M-31.8% | $343.72M-38.8% | $395.24M-31.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Charles River Laboratories's revenue?
- Charles River Laboratories (CRL) generated $4.0B in revenue over the trailing twelve months, up 0.1% year over year.
- Is Charles River Laboratories profitable?
- Charles River Laboratories is not currently profitable: it reported a net loss of $184.7M over the trailing twelve months, a -4.6% net margin.
- What are Charles River Laboratories's profit margins?
- Gross margin is 84.7% and operating margin is 13.0%, with a -4.6% net margin.
- What is Charles River Laboratories's earnings per share?
- Charles River Laboratories's diluted EPS over the trailing twelve months is $-3.70.
- Where does Charles River Laboratories's income statement data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
